(Circulation. 1995;92:2519-2525.)
© 1995 American Heart Association, Inc.
Articles |
From the Third Division, Department of Internal Medicine, Faculty of Medicine, Kyoto (Japan) University.
Correspondence to Akira Matsumori, MD, Third Division, Department of Internal Medicine, Faculty of Medicine, Kyoto University, 54 Kawaracho, Shogoin, Sakyo-ku, Kyoto 606, Japan.
Background Myocarditis is thought to be commonly caused by various viruses, and accumulating evidence links viral myocarditis with the eventual development of dilated cardiomyopathy. In many cases, however, the evidence is only circumstantial, and direct conclusive proof is not available. Polymerase chain reaction (PCR) has been used to detect enterovirus RNA in myocardial tissue, but the wide discrepancy in results emphasizes the need for further study.
Methods and Results We investigated hepatitis C virus infection in patients with dilated cardiomyopathy. The presence, type, and quantity of hepatitis C virus RNA were evaluated in the sera, and the presence of positive and negative strands of hepatitis C virus RNA in the heart was investigated with the PCR technique. Antihepatitis C virus antibody was present in the sera of 6 of 36 patients (16.7%) with dilated cardiomyopathy and in 1 of 40 patients (2.5%) with ischemic heart disease, showing a statistically significant (P<.05) difference. At an earlier time, acute myocarditis was suspected in 3 patients who had developed acute onset of heart failure, and the diagnosis was confirmed by endomyocardial biopsy in 1 patient. Hepatitis C virus RNA was present in the sera of 4 of the 6 patients, and all 4 had hepatitis C virus type II. The copy number of hepatitis C virus RNA in the serum was 8x102 to 2x103 genomes per 1 mL serum. Positive strands of hepatitis C virus were found in the hearts of 3 patients, and negative strands of hepatitis C virus were detected in the heart of 1 patient.
Conclusions The results suggest that hepatitis C virus infection is frequently found in patients with dilated cardiomyopathy and that hepatitis C virus is an important causal agent in the pathogenesis of the disease. Antiviral therapy against hepatitis C virus may be indicated in these patients.
Key Words: viruses heart failure myocarditis polymerase chain reaction cardiomyopathy
This article has been cited by other articles:
![]() |
J. W. Magnani and G. W. Dec Myocarditis: Current Trends in Diagnosis and Treatment Circulation, February 14, 2006; 113(6): 876 - 890. [Full Text] [PDF] |
||||
![]() |
A. Matsumori Hepatitis C Virus Infection and Cardiomyopathies Circ. Res., February 4, 2005; 96(2): 144 - 147. [Full Text] [PDF] |
||||
![]() |
T. Omura, M. Yoshiyama, T. Hayashi, S. Nishiguchi, M. Kaito, S. Horiike, K. Fukuda, S. Inamoto, Y. Kitaura, Y. Nakamura, et al. Core Protein of Hepatitis C Virus Induces Cardiomyopathy Circ. Res., February 4, 2005; 96(2): 148 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Ocel, W. D. Edwards, H. D. Tazelaar, L. M. Petrovic, B. S. Edwards, and P. S. Kamath Heart and Liver Disease in 32 Patients Undergoing Biopsy of Both Organs, With Implications for Heart or Liver Transplantation Mayo Clin. Proc., April 1, 2004; 79(4): 492 - 501. [Abstract] [PDF] |
||||
![]() |
I. D. Pavord, S. S. Birring, and H. Kanazawa COPD and Hepatitis C Chest, November 1, 2003; 124(5): 2035 - 2035. [Full Text] [PDF] |
||||
![]() |
F. Calabrese and G. Thiene Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects Cardiovasc Res, October 15, 2003; 60(1): 11 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kanazawa, K. Hirata, and J. Yoshikawa Accelerated Decline of Lung Function in COPD Patients With Chronic Hepatitis C Virus Infection: A Preliminary Study Based on Small Numbers of Patients Chest, February 1, 2003; 123(2): 596 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kanazawa, T. Mamoto, K. Hirata, and J. Yoshikawa Interferon Therapy Induces the Improvement of Lung Function by Inhaled Corticosteroid Therapy in Asthmatic Patients With Chronic Hepatitis C Virus Infection*: A Preliminary Study Chest, February 1, 2003; 123(2): 600 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Frustaci, F. Calabrese, C. Chimenti, M. Pieroni, G. Thiene, and A. Maseri Lone Hepatitis C Virus Myocarditis Responsive to Immunosuppressive Therapy Chest, October 1, 2002; 122(4): 1348 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fujioka, Y. Kitaura, A. Ukimura, H. Deguchi, K. Kawamura, T. Isomura, H. Suma, and A. Shimizu Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1920 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Feldman and D. McNamara Myocarditis N. Engl. J. Med., November 9, 2000; 343(19): 1388 - 1398. [Full Text] [PDF] |
||||
![]() |
S. Sasayama, A. Matsumori, and Y. Kihara New insights into the pathophysiological role for cytokines in heart failure Cardiovasc Res, June 1, 1999; 42(3): 557 - 564. [Full Text] [PDF] |
||||
![]() |
C. Kawai From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death : Learning From the Past for the Future Circulation, March 2, 1999; 99(8): 1091 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Kao, J.-J. Hwang, M. Okabe, K. Fukuda, K. Arakawa, and M. Kikuchi Hepatitis C Virus Infection and Chronic Active Myocarditis • Response Circulation, September 8, 1998; 98(10): 1044 - 1045. [Full Text] |
||||
![]() |
G N Dalekos, K Achenbach, D Christodoulou, G K Liapi, E K Zervou, D A Sideris, and E V Tsianos Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection Heart, September 1, 1998; 80(3): 270 - 275. [Abstract] [Full Text] |
||||
![]() |
H. Hanawa, T. Inomata, Y. Okura, S. Hirono, Y. Ogawa, T. Izumi, M. Kodama, and Y. Aizawa T Cells With Similar T-Cell Receptor ß-Chain Complementarity-Determining Region 3 Motifs Infiltrate Inflammatory Lesions of Synthetic Peptides Inducing Rat Autoimmune Myocarditis Circ. Res., July 27, 1998; 83(2): 133 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okabe, K. Fukuda, K. Arakawa, and M. Kikuchi Chronic Variant of Myocarditis Associated With Hepatitis C Virus Infection Circulation, July 1, 1997; 96(1): 22 - 24. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |